Wuxi Apptec (603259:SSE) earnings call transcripts
Earnings call transcripts for Wuxi Apptec, with a summary, the guidance given, and what analysts pressed on.
FreeSee Wuxi Apptec's financials in GloomOpen in browser →- Q2 2026 earnings call
Management framed growth as increasingly supported by later-stage molecule progression, rising capacity utilization and operating efficiency.
Aug 28, 2026Confident0.82 - written Q&A, August 27, 2026
Management framed the raised outlook as demand-led pipeline conversion, while emphasizing execution, capacity readiness and resilience amid geopolitical and currency headwinds.
Aug 28, 2026Positive0.48 - written Q&A, April 12, 2026
Management framed growth around CRDMO capacity expansion and operational efficiency, while offering little quantified detail on pricing, capital allocation or customer concentration.
Apr 13, 2026Mildly positive0.35 - written Q&A, November 11, 2025
Management framed durable CRDMO demand and capacity expansion as the growth engine, while emphasizing policy uncertainty and declining to quantify near-term peptide ramp or pricing effects.
Nov 12, 2025Mildly positive0.35 - written Q&A, August 28, 2025
Management framed the call around strong demand and execution, raising its full-year outlook while balancing shareholder returns with global capacity investment.
Aug 29, 2025Confident0.75